RXRX.NASDAQRecursion Pharmaceuticals, INC

Form 4: Recursion Pharmaceuticals CEO Christopher Gibson Reports Tax Withholding Share Transaction

Sentiment:

SEC Form 4

📋All filings for Recursion Pharmaceuticals, INC
🔒Login to Follow

Christopher Gibson, CEO of Recursion Pharmaceuticals, reports a transaction involving the withholding of shares to cover tax obligations.

Summary

  • On August 15, 2024, Christopher Gibson, the CEO of Recursion Pharmaceuticals, reported a transaction on SEC Form 4.
  • The transaction involved the withholding of 26,082 shares of Class A Common Stock by the issuer to satisfy tax obligations related to the net settlement of restricted stock units at a price of $6.69.
  • Following the transaction, Gibson directly owns 732,656 shares of Class A Common Stock.
  • Gibson also indirectly owns shares through LAHWRAN-3 LLC (486,000 shares), LAHWRAN-4 LLC (388,000 shares), and the Gibson Family Trust (67,875 shares).
  • He also holds options to purchase Class A Common Stock at various exercise prices and vesting schedules.

Sentiment

Score: 5

Explanation: This is a neutral report of an insider transaction related to tax obligations. It doesn't inherently indicate positive or negative sentiment.

Industry Context

This is a routine disclosure related to insider transactions and is a standard practice for executives of publicly traded companies.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders as it primarily concerns tax obligations of the CEO.

Key Dates

DateDescription
02/04/2022Date of expiration for some stock options.
03/01/2023Start date for vesting of some stock options.
03/01/2024Start date for vesting of some stock options.
08/15/2024Date of the reported transaction (share withholding for tax obligations).
08/19/2024Date of signature on the Form 4 filing.
12/30/2030Expiration date for some stock options.
02/04/2032Expiration date for some stock options.
02/01/2033Expiration date for some stock options.
02/09/2034Expiration date for some stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.